Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Avocado has gained attention as a supportive dietary component for Inflammatory Bowel Disorders (IBD), such as Crohn’s disease and ulcerative colitis, primarily due to its nutrient profile and potential anti-inflammatory effects. Several small-scale studies and animal models suggest that avocado’s monounsaturated fatty acids (notably oleic acid), dietary fiber, phytosterols, and polyphenols may positively influence gut health and inflammation. For instance, some research has indicated that avocado consumption is associated with increased gut microbial diversity and abundance of beneficial bacteria, which may help maintain intestinal barrier integrity—an important factor in IBD management. Additionally, certain compounds in avocado, such as persenone A, have shown anti-inflammatory activity in laboratory settings.

However, robust clinical evidence in humans is limited. Most data are observational or derived from general dietary recommendations rather than controlled trials specifically targeting IBD outcomes. No major clinical guidelines recommend avocado as a primary or adjunctive therapy for IBD, although it is often included in anti-inflammatory or Mediterranean-type diets, which are sometimes recommended for IBD patients. Thus, while there is some scientific rationale and preliminary evidence, the overall strength of evidence is weak to moderate, and avocado should be viewed as a supportive dietary choice rather than a proven therapeutic intervention for IBD.

More about avocado
More about Inflammatory Bowel Disorders

Other ingredients used for Inflammatory Bowel Disorders

Other health conditions supported by avocado

Products containing avocado